Publikationen

Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. SepNet Critical Care Trials Group. Intensive Care Med 2016 Dec; 42 (12): 1980-1989. Epub 2016 Sep 29.

Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of ED patients with dyspnea. Orhan Cinar, Cevik E, Acar A, Kaya C, Ardic S, Comert B, Yokusoglu M, Bilgi C, Meisner M., Madsen T, Am J Emerg Med. 2012 Nov;30(9):1915-20. doi: 10.1016/j.ajem.2012.04.009. Epub 2012 Jun 27.

Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis.

Antonia-Panagiota Georgopoulou, Athina Savva, Evangelos J. Giamarellos-Bourboulis, Marianna Georgitsi.....et al. M. Meisner (last author) on behalf of the Hellenic Sepsis Study Group.

Journal of Critical Care (2011), 26 (3):331.e1-7. DOI: 10.1016/j.jcrc.2010.07.012.

Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia.

Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJ.

Intensive Care Med. 2008 Nov;34(11):2084-91. doi: 10.1007/s00134-008-1173-x. Epub 2008 Jun 4.

Copetin, a novel prognostic biomarker in ventilator-associated pneumonia.

Renato Seligman, Jana Papassotiriou, Nils G Morgenthaler, Michael Meisner and Paulo JZ Teixeira. Crit Care. 2008;12(1):R11. doi: 10.1186/cc6780. PMID: 18252006.

Liberalisierte präoperative Flüssigkeitskarenz: Patientenzufriedenheit und klinische Praktikabilität bei elektiven laparoskopischen Eingriffen im Unterbauch

Michael Meisner, Ulrike Ernhofer, Joachim Schmidt. Zentralblatt für Chirurgie, 2008; 133 (5):479-485.

Kinetics of procalcitonin and c-reactive protein are strong predictors of survival in ventilator-associated pneumonia

Seligman Renato, Paulo José Zimmermann Teixeira, Michael Meisner, Thiago Lisboa, Felipe Teixeira Hertz, Jandyra M. G. Fachel. Crit Care 2006; 10, R125 1-9.

Correlation of Procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients

Michael Meisner, Heide Adina, Schmidt Joachim. Crit Care 2005; 10: R1 

Der Patient mit Ornithintranscarbamylase-Mangel. Schmidt J, Schroth, A. Irouschek, T. Birkholz, M. Kurzai, S. Kröber, M. Meisner, S. Albrecht. Anästhesist 2005; 54:1201-1208

Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection

Siassi Michael, Riese Jutta, Steffensen Rudi, Meisner Michael, Thiel Steffen, Hohenberger Werner, Schmidt Joachim. Critical Care 2005, 9: R483-R489 (DOI 10.1186/cc3768)

Procalcitonin als Marker der schweren Sepsis bei einer immunsupprimierten Patientin

Axer H, Wohlfart M, Meisner M, Finn S, Ragoschke-Schumm A, Mentzel HJ, Witte OW, Isenmann S.

Anasthesiol Intensivmed Notfall 2005; 40:97-102. DOI: 10.1055/s-2004-826115

[Procalcitonin as a marker for severe sepsis in an immunosuppressed patient].

Axer H, Wohlfarth M, Meisner M, Finn S, Ragoschke-Schumm A, Mentzel HJ, Witte OW, Isenmann S.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 Feb;40(2):97-102. German. PMID:15714400

Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction

Gian Paolo Castelli, Claudio Pognani, Michael Meisner, Antonio Stuani, Daniela Bellomi, Laura Sgarbi. Critical Care 2004, 8:R234-R232 (DOI 10.1186/cc2877) http://ccforum.com/content/8/4/R234

Letter to Clinica Chimica Acta. Clin Chim Acta 2003; 328:201

Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model.

Meisner M, Volker Müller, Zafar Khakpour, Eva Toegel, Heinz Redl. Shock 2003; 19 (2): 187-190.

Early increase of procalcitonin after cardiovascular surgery in patients with non-infectious and infectious postoperative complications.

Meisner M, C. Rauschmayer, J. Schmidt, R. Feyrer, R. Cesnjevar, Bredle D, Tschaikowsky K. Intensive Care Medicine 2002; 28(8) 1094-1102.

The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function.

Meisner M, T. Lohs, E. Hüttemann, J. Schmidt, M. Hüller, and K. Reinhart. European Journal of Anaesthesiology 2001; 18: 79-87. 

Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patient.

Meisner M, E. Hüttemann, T. Lohs, L. Kasakov, K. Reinhart. Shock 2001; 15: 171-175

Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin.

Meisner M, F.-M.-Brunkhorst, H.-B. Reith, J. Schmidt, H.-G. Lestin, K. Reinhart. Clinical Chemistry and Laboratory Medicine 2000, 38(10): 989-995

Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients.

Meisner M, E. Hüttemann, T. Lohs, L. Kasakov, K. Reinhart. European Journal of Anaesthesiology 2000; 17(11): 665-671.

The natural elimination rate of procalcitonin in patients with normal and impaired renal function.

Meisner M, J. Schmidt, H. Hüttner, K. Tschaikowsky. Intensive Care Med 2000; 26 (suppl.):S212-216

Ein semiquantitativer Schnelltest zur Bestimmung von Procalcitonin.

Meisner M, A. Rotgeri, F.-M. Brunkhorst. J Lab Med. 2000; 24 (2):76-85.  

Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shock.

Meisner M, Joachim Schmidt, Michael Schywalsky, Klaus Tschaikowsky. Internat. J. of Immunopharmacology 2000; 22: 83-90.  

Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA-scores during the course of sepsis and MODS. 

Meisner M, K. Tschaikowsky, T. Palmaers, J. Schmidt. Critical Care 1999; 3:45-50. 

Postoperative plasma concentrations of procalcitonin and C-reactive protein in patients undergoing cardiac an thoracic surgery with and without cardiopulmonary bypass.

Meisner M, K. Tschaikowsky, A. Hutzler, F. Harig, J. von der Emde. Cardiovascular Engineering 1998; 3(3/4): 174-178

Postoperative plasma concentrations of procalcitonin after different types of surgery.

Meisner M, K. Tschaikowsky, A. Hutzler, C. Schick, J. Schüttler. Intensive Care Medicine 1998; 24 (7) 680 - 684.

Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. Tschaikowsky, J. Schmidt, M. Meisner. Journal of Pharmacology and Experimental Therapeutics, 1998; 285 (2): 800-804.  

Blood volume determination using hydroxyethyl starch: A rapid and simple intravenous injection method. Tschaikowsky, M. Meisner, Regine Durst, Erich Rügheimer. Crit Care Med 1997; 25:599-60

Procalcitonin - influence of temperature, storage, anticoagulation and arterial and venous asservation of blood samples on procalcitonin - concentrations.

Meisner M, K. Tschaikowsky, S. Schnabel, J.Schmidt, A. Katalinic, J. Schüttler. European Journal of Clinical Chemistry and Clinical Biochemistry 1997; 35 (8)597-601

Procalcitonin (PCT) - indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices.

Meisner M, K. Tschaikowsky, J. Schmidt, J. Schüttler. Cardiovascular Engineering 1996; 1:67-76

Procalcitonin - ein neuer Diagnoseparameter bakterieller Inflammation und Sepsis.

Meisner M, K. Tschaikowsky, J. Schüttler. Anästhesiologie und Intensivmedizin 1996; 10(37): 529-539.

Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl xanthogenate (D609).

Tschaikowsky, M. Meisner, Frank Schönhuber, Erich Rügheimer. British Journal of Pharmacology 1994; 113:664-668.